Two COVID-19 vaccines have been approved for use in Australia.
Pfizer/BioNTech COVID-19 vaccine
Product name: COMIRNATY (BNT162b2 [mRNA]) COVID-19 VACCINE.
On January 25, 2021, Prime Minister Scott Morrison announced that the Therapeutic Goods Administration (TGA) had provisionally approved the BioPfizNTech COVID-19 vaccine for use in Australia. The TGA provisional COVID vaccine approval is for individuals 16 years of age and older.
Here is a new flyer from the Physicians for Informed Consent with information on the Pfizer/BioNTech COVID-19 vaccine
Downloadable PDF here
Should we use the word ‘vaccine’ for this new technology?
A vaccine for this is a misnomer. It is not a vaccine. It is an intermediary product which leads to the production of a protein that generates a so-called “vaccine”… and it is genetic engineering that has never been tested out in human beings before. And if it causes a problem a year, two years, five years down the line, and it has already been given to billions of people worldwide, it’s too late. You can’t take it out, you can’t switch it off, you can’t stop it. It’s in there.— Andrew Wakefield, MD
For more information about the mRNA technology have a listen to Kathy Scarborough from Vaccination Information SA who was interviewed by Matthew Pantellis on 5AA radio Adelaide.
AstraZeneca COVID-19 Vaccine
On February 16, 2021, the Therapeutic Goods Administration (TGA) granted provisional approval to AstraZeneca Pty Ltd for its COVID-19 vaccine, making it the second COVID-19 vaccine to receive regulatory approval in Australia.
The TGA does not conduct its own vaccine trials but depends on data obtained from the U.S Food and Drug Administration (FDA).
Explaining how the vaccine works, study lead author Professor Andrew Pollard, University of Oxford, UK, says: “The new vaccine is a chimpanzee adenovirus viral vector (ChAdOx1) vaccine that expresses the SARS-CoV-2 spike protein. It uses a common cold virus (adenovirus) that infects chimpanzees, which has been weakened so that it can’t cause any disease in humans, and is genetically modified to code for the spike protein of the human SARS-CoV-2 virus. This means that when the adenovirus enters vaccinated people’s cells it also delivers the spike protein genetic code. This causes these people’s cells to produce the spike protein, and helps teach the immune system to recognise the SARS-CoV-2 virus.”
It is not known whether these experimental vaccines have ever prevented transmission or reduced the number of deaths from the ‘virus’. The decision to approve them has been made of the basis of short term efficacy and safety data.
The Moderna COVID-19 vaccine
The Moderna COVID-19 vaccine (mRNA-1273) is made from synthetic genetic material that is immersed in fatty substances, including cholesterol and polyethylene glycol (PEG). More specifically, modified RNA molecules that encode for a mutated spike (S) protein antigen of the SARS-CoV-2 virus, the virus that can cause COVID-19, are immersed in lipid nanoparticles. The drug is administered in two intramuscular 100 mcg doses, 28 days apart.
From Moderna’s website:
Recognizing the broad potential of mRNA science, we set out to create an mRNA technology platform that functions very much like an operating system on a computer. It is designed so that it can plug and play interchangeably with different programs. In our case, the “program” or “app” is our mRNA drug – the unique mRNA sequence that codes for a protein
Does Moderna prevent hospitalisations or death?
Since only 10 hospitalized cases and one death of COVID-19 were observed, the clinical trial did not have enough statistical power to accurately measure the vaccine’s ability to prevent hospitalizations or deaths from COVID-19. The vaccine may be only 13% effective against hospitalized COVID-19 cases.
The FDA states,
A larger number of individuals at high risk of COVID-19 and higher attack rates would be needed to confirm efficacy of the vaccine against mortality.
The Moderna COVID-19 vaccine obtained emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) on Dec. 18, 2020, and is currently investigational.
Australia is buying 25 million doses of the Moderna vaccine. Health Minister Greg Hunt on May 13, 2021 confirmed the deal, which he said would see 1 million doses arrive by September and 9 million doses by December.
TGA provisionally approves the third Covid-19 vaccine – Janssen-Cilag Pty Ltd (known as Johnson & Johnson overseas)
This viral vector vaccine is provisionally approved and included in the Australian Register of Therapeutic Goods (ARTG) for the active immunisation for the prevention of coronavirus disease-2019 (COVID-19) in adults greater than or equal to 18 years of age. The official recommendation is for this vaccine to be given in a single dose. The Janssen vaccine is not included in Australia’s COVID-19 vaccination program.
TGA provisionally approves Moderna’s COVID-19 vaccine
On 9 August 2021, the Therapeutic Goods Administration (TGA), part of the Department of Health, granted provisional approval to Moderna Australia Pty Ltd for its COVID-19 vaccine – Spikevax (elasomeran) – making it the fourth COVID-19 vaccine to receive regulatory approval in Australia. This messenger RNA (mRNA) vaccine is provisionally approved and included in the Australian Register of Therapeutic Goods (ARTG) for active immunisation to prevent coronavirus disease-2019 (COVID-19) caused by SARS-CoV-2 in individuals 18 years of age and older. It is recommended that the vaccine is given in two doses that are administered 28 days apart.
Data to support the use of Moderna’s COVID-19 vaccine in adolescents aged 12 to 17 years are currently under evaluation and no specific concerns have been identified to date. The TGA’s decision on use in this age group will be announced separately.
Aborted human foetal cells in COVID vaccines
The COVID-19 Vaccine AstraZeneca (ChAdOx1-S) was produced in genetically modified human embryonic kidney cells. The cells are from aborted tissue obtained in the 1970s.
Astrazeneca’s shot is not the only COVID-19 vaccine to use aborted human cells in production. During the manufacture of their COVID-19 vaccines, Pfizer, Moderna and Johnson & Johnson also used specialised cells originally derived from aborted foetal tissue.
When the issue of aborted foetal cell lines arises the debate tends to revolve around the moral and ethical aspects of the use of aborted foetuses. However the use of such tissue can also result in damage to human health.
According to expert Dr Theresa Deisher: The adverse health effects of using of human foetal cell lines arise because:
Contaminating human DNA in these vaccines has the potential to trigger auto- immune responses and also the potential to become incorporated into our own genes, a process called homologous recombination
There are high levels of contaminants left in the vaccine. When the vaccine is manufactured using a chicken cell there are chicken contaminants and we recognise this as non human and it is eliminated from our bodies. However when the cell line used is from human foetal material this is human and we don’t eliminate the same species fragments from our body.
See: Testimony Submitted by: Dr. Theresa A. Deisher
COVID-19 Vaccine rollout begins in Australia
Sunday February 21, 2021
After a year of forced isolation, quarantine and lockdown, mandatory mask wearing and societal upheaval, the COVID vaccine rollout began. The rollout of the BioPfizNTech COVID-19 is to be carried out in phases with the first phase including quarantine and border workers, frontline health care workers and aged care and disability care staff.
Vaccine injury reporting
If you believe you or your child has suffered an adverse reaction to any vaccination, please fill in the form at VaxxTracker, VaxxTracker Global Vaccination Reporting.
You can also report directly to Australia’s Therapeutic Goods Administration (TGA) after filling in the details at VaxxTracker above.
Here is the link to TGA site AEMS Online
This is a link to a new page where you can find templates of letters to give to employers who insist on COVID-19 and Influenza jabs.